Skip to Main Content

Paper Details

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma.
Cancer Cell
7
2023
Author NameAffiliation
Antoni RibasUniversity of California, USA Parker Institute for Cancer Immunotherapy, USA Jonsson Comprehensive Cancer Center los angeles
Antoni RibasUniversity of California, USA Parker Institute for Cancer Immunotherapy, USA Jonsson Comprehensive Cancer Center los angeles
  • 1 - 2

Datasets

Release 1.2